Key facts
- RxSaveCard’s last known valuation is $17.5M (Nov 2025).
- It has raised $3.2M across 1 recorded rounds; the latest was Seed Round ($1.5M) in Nov 2025.
- Notable investors include Distributed Ventures, Rock Health Capital.
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for RxSaveCard
Funding rounds
1 roundsAbout RxSaveCard
Developer of pharmacy benefits and payment tools designed to get access to lower drug prices without changing their pharmacy benefit manager. The company's technology allows employers to set aside money for employees to use on prescription medications, enabling employees to save on their out-of-pocket costs.
- Sector
- Healthcare
- HQ
- Park Ridge, IL, United States
- Founded
- 2024
- Employees
- 8
- Website
- rxsavecard.com/
- Ownership
- Privately Held (backing)
RxSaveCard doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RxSaveCard shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RxSaveCard in its N-PORT filings yet. We sweep new filings monthly.